BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 16
• 17
• 19
• 20
• 21
• 22
• 23
• 24
• 26
• 27
• 28
• 29
• 30

• Drug Development

  DNAtrix Virus Expressing T-Cell Co-stimulator OX40L (CD252) Presented at the 2017 Society for Immunotherapy of Cancer Meeting

  Juan Fueyo, MD, Professor at MD Anderson Cancer Center Department of Neuro-Oncology, presented results of a comprehensive study on the oncolytic virus Delta-24-RGDOX at the 2017 Society for Immunotherapy of Cancer (SITC) Meeting, held in National Harbor, MD on November 10th - 12th.

  November 13, 2017

   · 

  2 min read
• Business

  Vote of Confidence in CollPlant: Completion of Agreement for Immediate Investment of USD 1.1 Million From Ami Sagi, One of the Company’s Largest Shareholders

  CollPlant announces that it has signed a private restricted investment agreement with Mr. Ami Sagi, one of the Company’s largest shareholders.

  November 13, 2017

   · 

  2 min read
• Pharm Country

  Avista Pharma Solutions Doubles API Manufacturing Capacity at Colorado Facility

  During this expansion, the site’s three existing GMP drug substance manufacturing suites were upgraded, and a fourth GMP suite was added.

  November 13, 2017

   · 

  3 min read
• Business

  ViewRay Inc. Reports Third Quarter 2017 Financial Results

  Total revenue of $12.2M in Q3 2017, up from $.04M in Q3 2016.

  November 13, 2017

   · 

  21 min read
• Business

  Medicenna Reports Second Quarter Fiscal 2018 Financial Results

  Medicenna today reported financial results for the three and six months ended September 30, 2017.

  November 13, 2017

   · 

  12 min read
• Genetown

  Rodin Therapeutics Announces Award of Grant Support From The Michael J. Fox Foundation to Advance Novel Treatment Strategy for Parkinson’s Disease

  MJFF is supporting Rodin’s work through two rounds of grant funding, totaling approximately $600,000.

  November 13, 2017

   · 

  3 min read
• Oragenics Regains Compliance With NYSE American Continued Listing Standards

  In a letter dated November 10, 2017, the Exchange notified the Company that it had successfully regained compliance with the NYSE American continued listing standards.

  November 13, 2017

   · 

  3 min read
• Trillium Therapeutics’ TTI-621 Program Featured at the Society for Immunotherapy of Cancer 32nd Annual Meeting

  Trillium Therapeutics announced today that new preclinical and clinical data from ongoing Phase 1 a/b trials for its CD47-blocking agent, TTI-621 (SIRPa-IgG1 Fc), were presented this weekend at the Society for Immunotherapy of Cancer 32nd Annual Meeting in National Harbor, Maryland USA.

  November 13, 2017

   · 

  6 min read
• 

  Business

  Cambridge’s PlaqueTec Names Former Dimension Therapeutics CEO as New Leader

  The life sciences leader will guide the company through its next growth phase and product launch in 2018.

  November 13, 2017

   · 

  4 min read
• Drug Development

  Neural Analytics Announces Data That Demonstrates Its Portable Transcranial Doppler Technology Can Accurately Measure Early Strokes

  Neural Analytics announced the results from the first phase of the EXPEDITE.

  November 13, 2017

   · 

  7 min read